rv001v
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 30, 2017 (NCT03199872)
Timeline
Indications
Studied for
Mechanism of action
- Transforming protein RhoA/Rho-related GTP-binding protein RhoCImmunity, active
Transforming protein RhoA/Rho-related GTP-binding protein RhoC immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04114825 | Phase 2 | Oct 31, 2019 | RhoVac, University of Copenhagen |
| NCT03199872 | Phase 1/Phase 2 (Phase 2) | Mar 30, 2017 | DanTrials ApS, Copenhagen, Denmark |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DanTrials ApS, Copenhagen, Denmark | For profit | 1 | 1 | 1 | 2017 |
| RhoVac | For profit | 1 | 1 | 1 | 2019 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1